Schweiz
Roche in der Schweiz
Führend in der Welt und zuhause
Roche sites in Switzerland
Did you know that …?
- Over the past three years, no other company has created more jobs in Switzerland than Roche.
- Roche pays a total of well over 1 billion Swiss francs a year in wages and salaries in Switzerland.
- With around 300 apprentices in 14 occupational fields and more than 100 special entry-level positions for young academics, Roche is one of the country’s biggest providers of education and training.
- In 2006, Roche provided a higher share of apprentices graduating with the highest marks in Basel-Stadt than any other company.
- In 1971, Roche was one of the first major companies in Switzerland to introduce an employee profit-sharing plan. Since then, all Roche employees in Switzerland have accrued the same benefits under the plan to supplement their occupational pension benefits.
- Roche’s Swiss companies employ people from around 70 different countries; women account for some 40% of the workforce.
- Roche is one of the four largest private-sector employers in the canton of Zug and in the region of Northwestern Switzerland.
- Every new job created in the pharmaceutical industry generates more than two additional jobs in the Swiss economy.
- Roche accounts for one in every 11 Swiss francs spent on R&D in this country.
- Roche is the country’s largest manufacturer of fully automated in-vitro diagnostic systems – over the last 39 years, more than 56,000 instruments have been produced at Rotkreuz.
- Roche is committed to the ambitious goal of reducing energy consumption per employee by ten per cent by 2010 (from 2005 levels).
- Roche exports generate a flow of 17,000 Swiss francs every minute – or 1 million Swiss francs an hour – into Switzerland.
- Roche’s purchases of goods and services from Swiss companies – including many SMEs – total roughly one-half to a full billion Swiss francs each year.
- At Roche Basel, around 1,000 people work in Development alone.
- In view of the genuine therapeutic advances that Roche’s innovative medicines offer patients and physicians, the Swiss regulatory authorities often assign priority reviews for Roche submissions. There were four such reviews in 2006, three in 2007, and more are to follow in 2008.
- In Switzerland and abroad, Roche is the largest Swiss pharmaceutical company (excluding generics and over-the-counter drugs).
- Every day, some 150,000 people with diabetes in Switzerland use Roche products, leading to greater independence and lower medical costs. Four out of five people using insulin pumps to treat diabetes choose a Roche product.
- The tax revenues generated by Roche – the company, employees, shareholders and suppliers – outstrip Roche’s sales in Switzerland.
- Roche is the only company to have introduced five cancer treatments in Switzerland that improve survival in patients.